Stockholm, Sweden – BoniPharmex, a joint venture between StartUpPharma Int. AB, a wholly-owned subsidiary of Barnik Invest Group, and DynalisPharma, today announced the successful nationwide distribution of its FilVel® product line across all major pharmacies in Sweden, including Apotek Hjärtat, Apoteket AB, Kronans Apotek, Doz Apotek, Apotea, MEDS Apotek, and Apohem.
BoniPharmex has developed a unique concept of dietary supplement products based on a holistic approach to health, considering the different stages of life. The company has achieved the development of 5 products in 2023 in accordance with EFSA (European Food Safety Authority) regulations. All products received EU Free Sales Certificates and are manufactured in EU-GMP facilities in Spain in accordance with HACCP principles, ensuring food safety.
The FilVel® product line has been well-received by consumers and healthcare professionals alike. This significant distribution achievement marks a major milestone for BoniPharmex, solidifying its position as a company with significant growth potential and well-positioned for future expansion in the Swedish dietary supplement market.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: hamid.bakhshi@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for small Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully-owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development phase to commercialization, enabling them to achieve positive cash flows or successful exits and ultimately enhancing patient well-being and improving human health worldwide. For more information visit www.barnikinvest.com.
